Patent assignee · US · COMPANY

Cytodiagnostics, Inc.

1Patents
0Active
1Granted
28Portfolio score

Filing activity: Sep 29, 1994 → Sep 29, 1994

Most-cited patents

PatentTitleAreaCited byStatus
US6025128A Prediction of prostate cancer progression by analysis of selected predictive parameters Emerging Cross-Sectional Technologies 177 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.